Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Marine sponge leads researchers to immune system regulator

12.11.2004


A Japanese brewery, an Okinawan sea sponge and some clever detective work have enabled an international research team based at the University of Chicago to solve a biological mystery, and the solution suggests a novel way to boost the body’s defenses against cancer.



In Science Express, the online early-publication version of the journal Science, the researchers provide evidence that a sugary lipid known as iGb3 plays a key role in regulating the response of natural killer T cells, a component of the immune system that plays an important role in preventing cancer, fighting infections and perhaps triggering or avoiding autoimmune diseases.

Discovered less than ten years ago, natural killer (NK) T cells are unusual because they target lipids, often bound to carbohydrates, rather than proteins. When presented with a lipid that may signal a threat, they pump out chemical signals, such interferon-gamma and interleukin-4, which tell other components of the immune system to rid the body of these invaders.


Mice with defects in this system are prone to cancer and susceptible to infections. On the other hand, misdirected NKT cells may play a role in autoimmune diseases, such as type-1 diabetes. "Until now we had no idea what activated NKT cells except for one curious compound, a glycosphingolipid derived from a marine sponge," said study author Albert Bendelac, "but once we learned that this compound could prevent the spread of cancer in mice, a lot of people became very interested."

Bendelac, M.D., Ph.D., a professor of pathology at the University of Chicago, is one of only a handful of immunologists who concentrate on NKT cells. Scientists know a great deal about how the immune system recognizes proteins, but comparatively little about this type of cell or the mechanisms the immune system uses to sort out lipids.

NKT cells are also odd in that they fall somewhere between the brute force of innate immunity and the flexible sophistication of adaptive immunity. They appear to have an ingrained ability to recognize some bacterial lipids. At the same time, they express less-variable versions of T-cell receptors. These stripped-down receptors enable NKT cells to respond to a limited array of lipid or carbohydrate antigens when presented in certain ways.

The only substance known to fully activate NKT cells through these receptors was the glycosphingolipid derived from an Okinawan sea sponge Agelas mauritianus. In the 1990s, researchers at the Kirin Brewery in Japan found this molecule alpha-Galactosyl-ceramide, by performing a pharmaceutical screen for natural compounds with anti-tumor activity. While this compound exhibited potent anti-cancer activity in vivo, there was no clue about the mechanism of action until researchers discovered that it was recognized by NKT cells.

A purified synthetic version, known as a-GalCer or KRN 7000, is now in phase-2 human clinical trials for several tumor types. One problem with a-GalCer, however, is that it can over-stimulate NKT cells. After a burst of activity and rapid secretion of interferon-gamma, NKT cells driven by a-GalCer essentially "burn out," disappearing from the circulation for weeks. "This sponge glycolipid, a-GalCer, is not a substance seen in mammals," said Bendelac. "But it pointed us toward similar molecules in our hunt for the natural substance that activates NKT cells."

Finding the natural activator -- what immunologist call the endogenous ligand -- for these cells is crucial to understanding their biology, he added, and might provide a gentler and more enduring way to get them to fight tumors.

Bendelac’s team developed several approaches to identify the endogenous ligand. One crucial clue came from the discovery of genetically deficient mice that have almost no NKT cells. Bendelac’s team found that these mice are unable to make an enzyme required to produce iGb3. Mice that lack this enzyme have a severe NKT cell deficiency, and are cancer prone. "We don’t yet know the real function of iGb3, how it works or even how to find and measure it in the body," Bendelac said, "but we suspect is serves as an alarm of some kind. It may be produced by cells that are stressed -- damaged by an infection or transformed into cancer cells. Then it alerts the immune system to the presence of cells in trouble."

Activating NKT cells may be particularly valuable for preventing or treating cancers that spread to the liver, where NKT cells are most common.

Understanding the role of iGb3 may also provide clues about autoimmune disease. NKT cells play an important, although still poorly understood, role in regulating all sorts of immune responses. Defects in the system may allow the body to attack itself, leading to chronic inflammation or tissue damage. "It has been extremely difficult to explore the mechanisms that govern the recruitment, activation and development of NKT cells without knowledge of the natural antigens recognized by these cells," said Bendelac. "Because of their role in regulating a range of diseases, this has been a source of intense research and speculation for years."

The National Institutes of Health supported this research. Additional authors were lead author Dapeng Zhou, plus Jochen Mattner, Yuval Sagiv and Kelly Hudspeth of the University of Chicago; Carlos Cantu, Nicolas Schrantz and Luc Teyton of the Scripps Research Institute; Ning Yin, Ying Gao and Paul Savage of Brigham Young University; Yunping Wu, Tadashi Yamashita and Richard Proia of the NIH; Susan Teneberg of Goteborg University, Sweden; Dacheng Wang of the Chinese Academy of Sciences; and Steven Levery of the University of New Hampshire.

John Easton | EurekAlert!
Further information:
http://www.uchospitals.edu

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>